NCT04454125

Brief Summary

This is a small pilot prospective intervention trial in children with asthma who will be randomized to receive either (A) Air Quality Index (AQI) education + an asthma action plan (control) or (B) AQI education + an asthma action plan which contains AQI behavioral recommendations + demonstrate ability to navigate to AirNow either online or on smartphone app (intervention).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable asthma

Timeline
Completed

Started Jul 2020

Shorter than P25 for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 1, 2020

Completed
13 days until next milestone

Study Start

First participant enrolled

July 14, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2021

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

August 15, 2023

Completed
Last Updated

August 31, 2023

Status Verified

August 1, 2023

Enrollment Period

8 months

First QC Date

June 26, 2020

Results QC Date

March 31, 2022

Last Update Submit

August 21, 2023

Conditions

Keywords

Air Quality Index (AQI)Childhood asthma exacerbations

Outcome Measures

Primary Outcomes (3)

  • Number of Participants With at Least One Moderate or Severe Asthma Exacerbation Over Time

    Moderate and severe asthma exacerbations were captured via questionnaire administered monthly for up to 6 months. Severe and moderate exacerbations were defined by American Thoracic Society (ATS) criteria.

    Over study duration (up to 6 months)

  • Mean Change in Asthma Control Over Time

    Asthma symptom control was measured by the validated Asthma Control Test (ACT) or Childhood Asthma Control Test (CACT) questionnaires as age appropriate (ACT in children 12 year of age or older; CACT for children younger than 12 years of age). ACT and CACT were obtained at baseline and every 4 weeks for up to 6 months. Differences in asthma control scores were compared both within arms and between arms at study end. ACT (min=5, max=25, score of \<=19 concerning for poor asthma control; \<=15 concerning for very poorly controlled). CACT (min=0, max=27, score of \<=19 concerning for poor asthma control; \<=12 concerning for very poorly controlled)

    Over study duration (up to 6 months)

  • Mean Change in Pediatric Asthma Quality of Life Over Time

    Quality of life will be measured by the validated Pediatric Asthma Quality of Life Questionnaire with standardized activities (PAQLQ) at entrance and exit visits. Differences in PAQLQ scores will be compared both within arms and between arms at study end. PAQLQ (min=1 (extremely bothered/all the time), max=7 (not bothered/none of the time)

    Baseline, 6 months

Secondary Outcomes (3)

  • Number of Participants Who Reported Checking the AQI Prior to Going Outside to be Active

    Over study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.

  • Number of Participated Who Reported Outdoor Activity Behavioral Change in Response to the AQI

    Over study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.

  • Number of Participants Who Reported Moderate or Vigorous Physical Activity for at Least 10 Minutes Continuously Outside in a Typical Week

    Over study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.

Study Arms (2)

Routine Care

ACTIVE COMPARATOR
Other: Routine care

AQI Intervention

EXPERIMENTAL
Behavioral: AQI intervention

Interventions

The intervention arm will receive AQI education, an asthma action plan containing AQI information and recommendations, and will be required to demonstrate ability to check AQI (either via airnow.gov website or downloaded AirNow smartphone app).

AQI Intervention

The routine care arm will be provided with general AQI education and an asthma action plan not containing AQI information.

Routine Care

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • physician diagnosis of persistent asthma- either mild, moderate, or severe;
  • family home internet access and/or smartphone access + willingness to download AirNow app on phone;
  • age 8-17 years.

You may not qualify if:

  • diagnosis of other chronic respiratory disease (e.g. cystic fibrosis, bronchopulmonary dysplasia, etc)
  • immunodeficiency- acquired or congenital
  • neuromuscular disease
  • disability affecting ambulation
  • cyanotic congenital heart disease
  • only 1 child per household eligible
  • no plans to leave Pittsburgh area in next 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPMC Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, 15224, United States

Location

Related Publications (2)

  • Reyes-Angel J, Han YY, Forno E, Celedon JC, Rosser FJ. Parental knowledge and usage of air quality in childhood asthma management. Front Pediatr. 2022 Oct 26;10:966372. doi: 10.3389/fped.2022.966372. eCollection 2022.

    PMID: 36440347BACKGROUND
  • Rosser FJ, Rothenberger SD, Han YY, Forno E, Celedon JC. Air Quality Index and Childhood Asthma: A Pilot Randomized Clinical Trial Intervention. Am J Prev Med. 2023 Jun;64(6):893-897. doi: 10.1016/j.amepre.2022.12.010. Epub 2023 Jan 13.

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Results Point of Contact

Title
Dr. Franziska Rosser
Organization
University of Pittsburgh

Study Officials

  • Franziska Rosser, MD MPH

    UPMC | Children's Hospital of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Unblinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 40 child will be 1:1 randomization by age groups 8-12 years, 13-17 years.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Pediatrics

Study Record Dates

First Submitted

June 26, 2020

First Posted

July 1, 2020

Study Start

July 14, 2020

Primary Completion

March 22, 2021

Study Completion

March 22, 2021

Last Updated

August 31, 2023

Results First Posted

August 15, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

The investigators do not currently have an individual participant data sharing plan. However, de-identified research data/documents may be shared in the future with other investigators who share similar research interests. Specimens and data will not be released without (1) PI written permission and (2) appropriate Institutional Review Board (IRB) approval. Data use and/or material transfer agreements will also be required as applicable to outside researchers.

Locations